Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Study Number: A151216
This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Closed to accrual for squamous cell carcinoma
- Navigator Ashton, 309-243-3611, email@example.com
- Amanda , 309-243-3663, firstname.lastname@example.org
- Jessica, 309-243-3615, email@example.com